表紙
市場調査レポート

再狭窄:世界の治験レビュー

Restenosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 244199
出版日 ページ情報 英文 88 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
再狭窄:世界の治験レビュー Restenosis Global Clinical Trials Review, H2, 2014
出版日: 2014年09月10日 ページ情報: 英文 88 Pages
概要

当レポートでは、世界の再狭窄治療薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、 概略以下の構成でお届けします。

目次

  • イントロダクション
    • 再狭窄
    • レポートガイダンス
  • 臨床試験: 地域別
  • 臨床試験: 国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験: 相別
  • 臨床試験: 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要: 主要企業
      • Abbott Laboratories
      • Cardio Research Enschede BV
      • Viron Therapeutics, Inc.
      • Revance Therapeutics, Inc.
      • AVI BioPharma Inc.
      • Lutonix, Inc.
      • Sahajanand Medical Technologies Pvt. Ltd.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • University Hospital Tubingen
      • Deutsches Herzzentrum Munchen
      • Jinling Hospital
      • Deutsches Herzzentrum Berlin
      • Second University of Naples
      • CHU Brest
      • 神戸市立医療センター中央市民病院
      • Heart Center Bad Krozingen
      • University of Rome "Tor Vergata"
      • University Hospital Gasthuisberg
      • Ospedale Santa Maria Goretti
      • The Cleveland Clinic
      • Seoul National University Hospital
      • 神戸大学
      • Far Eastern Memorial Hospital
      • Saarland University Hospital
      • Samsung Medical Center
      • University of Tampere
      • The University of Hong Kong
      • Flanders Medical Research Program
  • 5大臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Restenosis Global Clinical Trials Review, H2, 2014" provides data on the Restenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Restenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Restenosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Restenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Restenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Restenosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Restenosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sarepta Therapeutics, Inc.
      • Clinical Trial Overview of Sarepta Therapeutics, Inc.
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Novogen Limited
      • Clinical Trial Overview of Novogen Limited
      • Mercator MedSystems, Inc.
      • Clinical Trial Overview of Mercator MedSystems, Inc.
      • Chugai Pharma USA, LLC
      • Clinical Trial Overview of Chugai Pharma USA, LLC
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • C. R. Bard, Inc.
      • Clinical Trial Overview of C. R. Bard, Inc.
      • Angelini Group
      • Clinical Trial Overview of Angelini Group
    • Clinical Trial Overview of Top Institutes / Government
      • Jinling Hospital
      • Clinical Trial Overview of Jinling Hospital
      • Deutsches Herzzentrum Munchen
      • Clinical Trial Overview of Deutsches Herzzentrum Munchen
      • University Hospital Tubingen
      • Clinical Trial Overview of University Hospital Tubingen
      • University of Rome II
      • Clinical Trial Overview of University of Rome II
      • University of Roma La Sapienza
      • Clinical Trial Overview of University of Roma La Sapienza
      • Hiroshima University Hospital
      • Clinical Trial Overview of Hiroshima University Hospital
      • French Cardiology Society
      • Clinical Trial Overview of French Cardiology Society
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
      • Nantes University Hospital
      • Clinical Trial Overview of Nantes University Hospital
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Restenosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Restenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Restenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Restenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Restenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Restenosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Restenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Restenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Restenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Restenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Restenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Restenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Restenosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Restenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Restenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Restenosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Restenosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Restenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novogen Limited, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mercator MedSystems, Inc., 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chugai Pharma USA, LLC, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. R. Bard, Inc., 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Angelini Group, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jinling Hospital, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsches Herzzentrum Munchen, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rome II, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Roma La Sapienza, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French Cardiology Society, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2014*
  • Restenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*

List of Figures

  • Restenosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Restenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Restenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Restenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Restenosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Restenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Restenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Restenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Restenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Restenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Restenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Restenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Restenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Restenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Restenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top